Source comparison
Mechanism of Intracellular Signalling: Gαs vs Gαq
The intracellular signalling cascade difference between GHRHR (CJC-1295) and GHS-R1a (GHRP-6) is a fundamental research design consideration. GHRHR couples to Gαs, activating adenylate cyclase, elevating cAMP, and activating PKA — which phosphorylates CREB and
This comparison does not assign a generated winner or score.
- The intracellular signalling cascade difference between GHRHR (CJC-1295) and GHS-R1a (GHRP-6) is a fundamental research design consideration. GHRHR couples to Gαs, activating adenylate cyclase, elevating cAMP, and activating PKA — which phosphorylates CREB and drives Pit-1-dependent GH gene transcription. This is a transcription-dominant, sustained signal with moderate calcium-independent component.
- GHS-R1a couples primarily to Gαq, activating PLC-β, generating IP3 and DAG, and triggering IP3-receptor-mediated calcium release from the endoplasmic reticulum. The calcium signal drives rapid GH vesicle exocytosis — a faster but more transient secretory event than the GHRHR-cAMP mechanism. GHS-R1a also signals through Gαi (inhibiting cAMP in some tissues) and through β-arrestin (internalisation, receptor desensitisation).
- The practical research consequence: CJC-1295 is superior for studying sustained GH effects, IGF-1 plateau elevation, and anabolic biology requiring prolonged GH exposure. GHRP-6 is superior for studying acute GH pulse physiology, pituitary somatotroph reserve (combined GHRH+GHRP-6 test), and GHS-R1a biology in peripheral tissues that do not express GHRHR. Critically, GHRP-6 effects outside the GH axis — including ACTH/cortisol co-secretion and hepatoprotective mechanisms — require GHS-R1a rather than GHRHR and cannot be reproduced by CJC-1295.